Abstract Details

Title Population Pharmacokinetic (PK) Evaluation and Missed Dose Simulations for Eslicarbazepine Acetate (ESL) Monotherapy

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 258

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Soujanya Sunkaraneni PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
David E. Blum, MD	Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
	No disclosure on file
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.

��ɫ��